Smoking and HIV: what are the risks and what harm reduction strategies do we have at our disposal?

by Michelle L. Giles, Coral Gartner, Mark A. Boyd
Published 2018-12-01

Sociodemographic, lifestyle and metabolic predictors of all-cause mortality in a cohort of community-dwelling population: an 18-year follow-up of the North West Adelaide Health Stu...

by Yohannes Adama Melaku, Sarah L Appleton, Mark A Boyd
Published 2019-08-01

Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection

by Gerald Mak, John J. Zaunders, Michelle Bailey, Nabila Seddiki, Geraint Rogers, Geraint Rogers, Lex Leong, Tri Giang Phan, Tri Giang Phan, Anthony D. Kelleher, Kersten K. Koelsch, Mark A. Boyd, Mark A. Boyd, Mark A. Boyd, Mark Danta, Mark Danta
Published 2021-05-01

Correction to: Exploring the readiness of senior doctors and nurses to assess and address patients’ social needs in the hospital setting

by Katherine J. Lake, Mark A. Boyd, Lisa Smithers, Natasha J. Howard, Anna P. Dawson
Published 2022-03-01

Exploring the readiness of senior doctors and nurses to assess and address patients’ social needs in the hospital setting

by Katherine J. Lake, Mark A. Boyd, Lisa Smithers, Natasha J. Howard, Anna P. Dawson
Published 2022-02-01

Impact of health literacy and its interventions on health outcomes in those with atrial fibrillation: a systematic review protocol

by Rajiv Mahajan, Mark A Boyd, Nathan O'Callaghan, Kyle B Franke, Timothy Lathlean, Don Kieu
Published 2022-12-01

Preventing empirical antibiotic treatment failure in migrant populations: screening by infection risk, not ethnic background

by Steven L. Taylor, Lito E. Papanicolas, Erin Flynn, Mark A. Boyd, Steve L. Wesselingh, Geraint B. Rogers
Published 2023-09-01

Moving away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE)--agents that concern prescribers and patients: a feasibility study and call for a trial.

by Amit C Achhra, Mark A Boyd, Matthew G Law, Gail V Matthews, Anthony D Kelleher, David A Cooper
Published 2014-01-01

The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa.

by Karen Schneider, Chidi Nwizu, Richard Kaplan, Jonathan Anderson, David P Wilson, Sean Emery, David A Cooper, Mark A Boyd
Published 2013-01-01

Capturing the social determinants of health at the individual level: a pilot study

by Kate E Neadley, Gai McMichael, Toby Freeman, Kathryn Browne-Yung, Fran Baum, Elaine Pretorius, Karen Taylor, Mark A Boyd
Published 2021-06-01

Development of recommendations for a minimum dataset for Identifying Social factors that Stratify Health Opportunities and Outcomes (ISSHOOs) in pain research

by Emma L. Karran, Aidan G. Cashin, Trevor Barker, Mark A. Boyd, Alessandro Chiarotto, Vina Mohabir, Jennifer Petkovic, Saurab Sharma, Peter Tugwell, G. Lorimer Moseley
Published 2024-06-01

The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study

by Swe Swe Thit, Ne Myo Aung, Zaw Win Htet, Mark A. Boyd, Htin Aung Saw, Nicholas M. Anstey, Tint Tint Kyi, David A. Cooper, Mar Mar Kyi, Josh Hanson
Published 2017-08-01

HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-l...

by Allison Martin, Cecilia L Moore, Patrick W G Mallon, Jennifer F Hoy, Sean Emery, Waldo H Belloso, Praphan Phanuphak, Samuel Ferret, David A Cooper, Mark A Boyd, Second-Line Study Team
Published 2013-01-01

Investigating potential transmission of antimicrobial resistance in an open-plan hospital ward: a cross-sectional metagenomic study of resistome dispersion in a lower middle-income...

by Anushia Ashokan, Josh Hanson, Ne Myo Aung, Mar Mar Kyi, Steven L. Taylor, Jocelyn M. Choo, Erin Flynn, Fredrick Mobegi, Morgyn S. Warner, Steve L. Wesselingh, Mark A. Boyd, Geraint B. Rogers
Published 2021-03-01

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis

by Nathan W. Cummins, Jacqueline Neuhaus, Haitao Chu, James Neaton, Christoph Wyen, Jürgen K. Rockstroh, Daniel J. Skiest, Mark A. Boyd, Saye Khoo, Margalida Rotger, Amalio Telenti, Richard Weinshilboum, Andrew D. Badley
Published 2015-07-01

Exploring self-determined solutions to service and system challenges to promote social and emotional wellbeing in Aboriginal and Torres Strait Islander people: a qualitative study

by Anna P. Dawson, Anna P. Dawson, Eugene Warrior, Odette Pearson, Odette Pearson, Mark A. Boyd, Mark A. Boyd, Judith Dwyer, Kim Morey, Tina Brodie, Kurt Towers, Sonia Waters, Cynthia Avila, Courtney Hammond, Katherine J. Lake, Katherine J. Lake, ‘Uncle’ Frank Lampard, ‘Uncle’ Frank Lampard, ‘Uncle’ Frank Wanganeen, Olive Bennell, Darrien Bromley, Toni Shearing, Nathan Rigney, Schania Czygan, Nikki Clinch, Andrea Pitson, Alex Brown, Alex Brown, Natasha J. Howard, Natasha J. Howard
Published 2023-09-01

Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region.

by Stephen Wright, Mark A Boyd, Evy Yunihastuti, Matthew Law, Thira Sirisanthana, Jennifer Hoy, Sanjay Pujari, Man Po Lee, Kathy Petoumenos, International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific HIV Observational Database (APHOD)
Published 2013-01-01

CD4+ T follicular helper and IgA+ B cell numbers in gut biopsies from HIV-infected subjects on antiretroviral therapy are comparable to HIV-uninfected individuals

by John Zaunders, Mark Danta, Michelle Bailey, Gerald Mak, Katherine Marks, Nabila Seddiki, Yin Xu, David J Templeton, David J Templeton, David J Templeton, David A Cooper, Mark A Boyd, Anthony Dominic Kelleher, Kersten K Koelsch
Published 2016-10-01

The ‘what’ and ‘how’ of screening for social needs in healthcare settings: a scoping review

by Emma L. Karran, Aidan G. Cashin, Trevor Barker, Mark A. Boyd, Alessandro Chiarotto, Omar Dewidar, Jennifer Petkovic, Saurab Sharma, Peter Tugwell, G. Lorimer Moseley, Identifying Social Factors that Stratify Health Opportunities and Outcomes (ISSHOOs) Collaborative Core Research Group
Published 2023-04-01

Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infect...

by Janaki Amin, Mark A Boyd, Nagalingeswaran Kumarasamy, Cecilia L Moore, Marcello H Losso, Chidi A Nwizu, Lerato Mohapi, Stephen J Kerr, Annette H Sohn, Hedy Teppler, Boris Renjifo, Jean-Michel Molina, Sean Emery, David A Cooper
Published 2015-01-01